Revive Therapeutics Ltd (RVVTF)

[Obtuse Eye]

Serious question. Not an attempt to be snarky or creating "gotcha" opportunities.

Do you sincerely believe that it is just because of a lack of data that Revive hasn't gotten any run with their therapeutics? I realize their testing has been sparse, but if the WHO, CDC, NIH, and others (The Sciences) were truly interested in seeing these types of things get to market, they would turn every stone. This includes funding to make sure clinical/trial testing is robust enough to obtain the needed sample size.

What we have instead, is a drug maker who get to push through, whatever they call good, at will. At the point where efficacy was learned to be diminishing, that "vaccine" should have been flagged and any subsequent "vaccines or boosters" should have been scrutinized much more heavily than they were

What we also have is a therapeutic (Monoclonal anti-bodies) that have been widely used, and have an enormous success rate, suddenly taken over and the distribution of it being scrutinized. What happens now with that one is it will be given to someone who is really in need and is well connected.

Meanwhile, the therapeutics that are most effective between day-1 and day-5 of infection, are only being administered after an individual is admitted to the hospital and likely past day-10.